LEXON
13.4.2021 09:32:11 CEST | Business Wire | Press release
Lexon today announced that it has received 6 Red Dot Awards for its outstanding product design quality in multiple categories, setting a new company record for the number of awards won in a single competition. Sister company MyKronoz also takes home a Red Dot Award for its MyScale , a smart and design body scale with a large and intuitive color display.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210413005520/en/
This announcement comes only a few weeks after Lexon’s best-selling Oblio was honored with two prestigious international prizes - a TIME Best Invention Award and a CES Innovation Award - confirming the French brand’s continued leadership in innovative product design, with a total of more than 200 awards received since its creation in 1991.
“2021 marks the 30th anniversary of Lexon, so this exceptional recognition comes at a perfect timing. We couldn’t be happier to celebrate this milestone with such paramount achievement which proves our consistent ability to create objects that combine aesthetics and function, but most importantly, that are part of our daily lives.
2021 is also synonymous with the global crisis, one that inevitably led us to adapt our business to new realities, to rethink our products portfolio and to focus even more on designing solutions that truly meet our changing environments, whether it’s for the home, the work or the new mobility.
Today, these distinctions not only celebrate our resilience, they also validate the quality of the experience we strive to bring to our customers in all circumstances,” says Boris Brault, Lexon’s CEO.
Since its acquisition by BOW Group in 2018, Lexon has experienced significant online growth and staggering expansion in the US where the brand is today listed among the most prominent retailers including Target, Nordstrom, Neiman Marcus, Best Buy and MoMA Design Store. In the coming weeks, Lexon will pursue its international development by completing the takeover of its long-term Chinese Master License who has built the brand domestically for the past 10 years, opening more than 80 retail stores, developing online sales on JD.com and Taobao, as well as growing profitable B2B activities.
The successful integration of Lexon among BOW Group has created highly valuable synergies with sister company MyKronoz, in terms of product design, R&D capabilities, sales channels and digitalization. BOW Group has thereby proven its ability to acquire external companies within its manufacturing, selling and distribution structures to scale its business operations. Today, the Group is looking at new opportunities to further enlarge its portfolio with product offering and services, in order to become a leading 360° platform of lifestyle consumer tech.
The Lexon award-winning products include:
Oblio :
A must-have innovation for today’s world, Oblio is a sleek UV-C sanitizer that prevents the spread of harmful bacteria found on our smartphones. Using its built-in UV-C LED technology located on its front interior, Oblio can deliver a 360° disinfection by simply flipping the phone to expose each surface for a 20-minute sanitizing cycle. Oblio’s efficiency has been proven through lab testing to kill 99.9% of viruses present on the surface of smartphones, including H1N1.
Also acting as a 10W wireless charger, Oblio can fully charge a smartphone in 3 hours. Its discrete vase-like shape makes it a beautiful design item that can be proudly displayed in a home or office, encouraging a break from your screen while your phone is being fast-charged and deeply sanitized.
Compatible with all mobile phones for sanitizing function, and all Qi-enabled smartphones such as the latest iPhone & Android devices for the wireless charging function.
MSRP: 79.90 $/€
Mino T : Made for exploring, Mino T is an outdoor speaker designed with a sleek carabiner to clip to your bag or bike. Boasting an IPX4 water resistance combined with an ultra-robust finish, it is ready to follow you in all your adventures. Carefully engineered with a passive bass system, Mino T allows you to enjoy a more balanced, fuller sound on the go with up to 5h of continuous playtime. Built with a considered design in mind, this speaker is also a stand-alone modern piece that you can proudly display indoors, on its matching stand.
MSRP: 49.90 $/€
Mina M :
With its compact size, statement-making aluminum base and water-resistant casing, the Mina M is the perfect way to inspire any space, indoor and out. Mina M brings an impressive 9 LED light color range to your bedside, workspace, or patio. The color change and dimming function are all controlled by a press down feature on the top of the light. Mina M is rechargeable using any Qi-enabled wireless charging station. You can also charge Mina M by using a USB-C charging cable. The Mina M has up to 24h of battery life from a single charge, making it the perfect companion all day and night.
MSRP: 49.90 $/€
Mino+ :
This mini portable Bluetooth® speaker fits in the palm of your hand to deliver an impressive 3W sound quality for up to 3 hours! Mino+ offers two charging methods: wirelessly with any Qi charging pad or via its USB-C port. When connected to your phone, you can use Mino+ to take selfies, start and stop recording videos, and answer calls using the bottom button.
Thanks to its built-in TWS technology, you can connect two Mino+ together and double the pleasure with an immersive stereo sound. Mino+ comes in 3 finishes (aluminum, chrome and glossy) and 24 colors to bring a stylish touch to your decor.
MSRP: 29.90 $/€
These four products have been designed in collaboration with Manuela Simonelli & Andrea Quaglio.
No connector, no cable: PowerSound is a revolutionary 2-in-1 device that combines a 5000 mAh wireless power bank with a 360° Bluetooth speaker, while charging and recharging itself entirely wirelessly. Capable of charging all Qi-enabled smartphones or earbuds, it can be recharged by setting it on top of any wireless station. Thanks to its 5W built-in Bluetooth® speaker, PowerSound allows you to enjoy an immersive sound for up to 20 hours. Easy to carry and ultra-stylish, PowerSound has a smooth design crafted from durable synthetic leather and fabric.
MSRP: 79.90 $/€
C-Pen :
The C-Pen offers a unique 2-in-1 writing and storage experience. A ballpoint pen with a 32 GB USB-C memory drive thoughtfully engineered into the pencap. 32 GB of memory means you can transfer and store up to 4000 pictures, 7000 songs, or 40 hours of video. Compatible with computers, tablets, and smartphones with a USB-C port, the C-Pen is a handy way to transfer memories or notes between all your devices. The must have accessory for the modern on-the-go person, available in 6 colors in a glossy or matt finish and working with a universal refill.
MSRP:39.90 $/€
These two products have been designed in collaboration with Alain Berteau.
About the Red Dot Award:
The Red Dot Award - Product Design, whose origins date back to 1955, appraises the best products created every year. In roughly 50 categories , manufacturers and designers can enter their innovations in the competition. According to the motto “In search of good design and innovation”, the jury evaluates the entries and only awards a Red Dot to products that win them over with their high design quality.
About Lexon:
Since its creation in 1991, Lexon has relentlessly pushed the limits and created a difference in the world of design while remaining true to its commitment to make small objects useful, beautiful, innovative and affordable. Whether in electronics, audio, travel accessories, office or leisure, Lexon has established a special relationship with creativity and partnered with the best designers around the world to create timeless collections of lifestyle products. Following its recent acquisition by BOW Group, a global player in the lifestyle and wearable consumer markets, Lexon is writing a new chapter in its history, experiencing a staggering international growth and digital expansion. Today, with 30 years of existence, more than 200 awards, collaboration with some of the most renowned designers, a retail presence in more than 90 countries across the Globe, Lexon has truly established itself as a worldly-known French design brand.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005520/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
